SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments
SARS-CoV-2: 감염 및 백신 및 치료제 개발로 유발되는 면역 반응
Review
[키워드] acute respiratory syndrome coronavirus
addition
administration
affected
antiparasitic
antivirals
approach
approved
caused
characterized
clinical
clinical evidence
clinical manifestation
clinical manifestations
Clinical stages
clinical trial
clinical trials
contribute
convalescent serum
coronavirus
coronavirus 2
coronavirus disease
COVID-19
COVID-19 disease
current therapy
deaths
described
development
disease
distress
drug
dry cough
effective
Evidence
exacerbated
FDA
Fever
food
Food and Drug Administration
headache
Health Organization
Human
Hydroxychloroquine
immune
Immune cell
immune cells
immune response
immunological
imperative
Infection
Infectious disease
information
mediators
Migration
monoclonal antibody
monoclonal antibody therapy
neutralize
organ
pandemic
Phase III clinical trials
potential therapy
Prevent
proinflammatory mediator
proinflammatory mediators
respiratory
respiratory distress
response
SARS-CoV-2
SARS-CoV-2 patients
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
Severe case
severe cases
Symptom
tested
therapy
Treatment
treatments
Vaccine
vaccine candidate
Vaccines
virus
WHO
World Health Organization
[DOI] 10.3389/fimmu.2020.569760 PMC 바로가기 [Article Type] Review
[DOI] 10.3389/fimmu.2020.569760 PMC 바로가기 [Article Type] Review